stockportfolio.pro
NeoGenomics, Inc. Gross Profit 2010–2025
NeoGenomics, Inc. (NEO) annual gross profit by fiscal year, computed from SEC filings. Compound growth +22.1%/yr over 15 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $314.29M | 43.2% | +8.3% |
| FY 2024 | $290.10M | 43.9% | +18.6% |
| FY 2023 | $244.60M | 41.3% | +30.2% |
| FY 2022 | $187.90M | 36.9% | +0.4% |
| FY 2021 | $187.06M | 38.6% | +0.6% |
| FY 2020 | $185.89M | 41.8% | -5.6% |
| FY 2019 | $196.84M | 48.1% | +54.7% |
| FY 2018 | $127.27M | 46.0% | +24.8% |
| FY 2017 | $101.96M | 42.4% | +3.9% |
| FY 2016 | $98.10M | 42.3% | +124.2% |
| FY 2015 | $43.76M | — | +7.5% |
| FY 2014 | $40.71M | — | +28.3% |
| FY 2013 | $31.74M | — | +18.3% |
| FY 2012 | $26.84M | — | +38.1% |
| FY 2011 | $19.43M | — | +23.1% |
| FY 2010 | $15.78M | — | — |
Source: NeoGenomics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for NeoGenomics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeoGenomics, Inc. — frequently asked questions
What is NeoGenomics, Inc.'s gross profit?
NeoGenomics, Inc. (NEO) reported gross profit of $314.29M for fiscal year 2025, per its SEC filings.
How has NeoGenomics, Inc.'s gross profit changed over time?
Between fiscal 2010 and 2025, NEO's gross profit grew at roughly 22.1% per year (compound annual rate), from $15.78M to $314.29M.
Where does this data come from?
Figures are computed from NeoGenomics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.